High expression of serum miR-17-5p associated with poor prognosis in patients with hepatocellular carcinoma

Hepato-Gastroenterology

Volumn 60, Issue 123, 2013, Pages 549-552

  Zheng, Jianjian ^a   Dong, Peihong ^a   Gao, Shenmeng ^a   Wang, Ni ^a   Yu, Fujun ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Biomarker; Hepatocellular carcinoma; miR 17 5P; Prognosis

Indexed keywords

MICRORNA; MICRORNA 17 5P; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; FEMALE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VOLUME; UPREGULATION;

CARCINOMA, HEPATOCELLULAR; FEASIBILITY STUDIES; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84874537555     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge12754     Document Type: Article

References (26)

1. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116:281-297.
2. Calin GA, Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6:857-866. (Pubitemid 44629897)
3. Calin GA, Dumitru CD, Shimizu M, et al: Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002; 99:15524-15529. (Pubitemid 35403967)
4. Chen L, Jiang M, Yuan W, et al: miR-17-5p as a novel prognostic marker for hepatocellular carcinoma. J Invest Surg 2012; 25:156-161.
5. Cortez MA, Calin GA: MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases. Expert Opin Biol Ther 2009; 9:703-711.
6. Esquela-Kerscher A, Slack FJ: Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6:259-269.
7. Fabbri M, Croce CM, Calin GA: MicroRNAs. Cancer J 2008; 14:1-6.
8. Gui J, Tian Y, Wen X, et al: Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies. Clin Sci (Lond) 2011; 120:183-193.
9. He L, Hannon GJ: MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004; 5:522-531. (Pubitemid 38868508)
10. Hossain A, Kuo MT, Saunders GF: Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA. Mol Cell Biol 2006; 26:8191-8201. (Pubitemid 44631015)
11. Huang Z, Huang D, Ni S, et al: Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 2010; 127:118-126.
12. Ji X, Takahashi R, Hiura Y, et al: Plasma miR-208 as a biomarker of myocardial injury. Clin Chem 2009; 55:1944-1949.
13. Lau H, Fan ST, Ng IO, et al: Long term prognosis after hepatectomy for hepatocellular carcinoma: a survival analysis of 204 consecutive patients. Cancer 1998; 83:2302-2311. (Pubitemid 28533499)
14. Lawrie CH, Gal S, Dunlop HM, et al: Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 2008; 141:672-675 (Pubitemid 351667616)
15. Liu XG, Zhu WY, Huang YY, et al: High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer. Med Oncol 2012; 29:618-626.
16. Mitchell PS, Parkin RK, Kroh EM, et al: Circulating microR-NAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 2008; 105:10513-10518.
17. Murakami Y, Yasuda T, Saigo K, et al: Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 2006; 25:2537-2545.
18. Parkin DM, Bray F, Ferlay J, et al: Global cancer statistics, 2002. CA Cancer J Clin 2005; 55:74-108. (Pubitemid 40372904)
19. Qu KZ, Zhang K, Li H, et al: Circulating microRNAs as biomarkers for hepatocellular carcinoma. J Clin Gastroenterol 2011;45:355-360.
20. Schrauder MG, Strick R, Schulz-Wendtland R, et al: Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection. PLoS One 2012; 7(1):e29770.
21. Takakura S, Mitsutake N, Nakashima M, et al: Oncogenic role of miR-17-92 cluster in anaplastic thyroid cancer cells. Cancer Sci 2008; 99:1147-1154. (Pubitemid 351676626)
22. Volinia S, Calin GA, Liu CG, et al: A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 2006; 103:2257-2261. (Pubitemid 43271657)
23. Wang GK, Zhu JQ, Zhang JT, et al: Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J 2010; 31:659-666.
24. Xu J, Wu C, Che X, et al: Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis. Mol Carcinog 2011; 50:136-142.
25. Yang F, Yin Y, Wang F, et al: miR-17-5p Promotes migration of human hepatocellular carcinoma cells through the p38 mitogen-activated protein kinase-heat shock protein 27 pathway. Hepatology 2010; 51:1614-1623.
26. Yao J, Liang L, Huang S, et al: MicroRNA-30d promotes tumor invasion and metastasis by targeting Galphai2 in hepatocellular carcinoma. Hepatology 2010; 51:846-856.